Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives
| dc.contributor.author | Evranos-Aksoz, Begüm | |
| dc.contributor.author | Baysal, İpek | |
| dc.contributor.author | Yabanoğlu-Çiftçi, Samiye | |
| dc.contributor.author | Djikic, Teodora | |
| dc.contributor.author | Yelekçi, Kemal | |
| dc.contributor.author | Uçar, Gülberk | |
| dc.contributor.author | Ertan, Rahmiye | |
| dc.date.accessioned | 2019-06-27T08:02:11Z | |
| dc.date.available | 2019-06-27T08:02:11Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | A group of 35-diaryl-2-pyrazoline and hydrazone derivatives was prepared via the reaction of various chalcones with hydrazide compounds in ethanol. Twenty original compounds were synthesized. Ten of these original compounds have a pyrazoline structure nine of these original compounds have a hydrazone structure and one of these original compounds has a chalcone structure. Structural elucidation of the compounds was performed by IR H-1 NMR C-13 NMR mass spectral data and elemental analyses. These compounds were tested for their inhibitory activities toward the A and B isoforms of human monoamine oxidase (MAO). Except for 3k and 6c all compounds were found to be competitive reversible and selective inhibitors for either one of the isoforms (hMAO-A or MAO-B). Compounds 3k and 6c were found to be competitive reversible but non-selective MAO inhibitors. Compound 6h showed hMAO-B inhibitory activity whereas the others potently inhibited hMAO-A. Compound 5c showed higher selectivity than the standard drug moclobemide. According to the experimental K-i values compounds 6i 6d and 6a exhibited the highest inhibitory activity toward hMAO-A. The AutoDock 4.2 program was employed to perform automated molecular docking. The calculated results obtained computationally were in good agreement with the experimental values. | en_US] |
| dc.identifier.doi | 10.1002/ardp.201500212 | en_US |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issn | 1521-4184 | |
| dc.identifier.scopus | 2-s2.0-84942987491 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12469/569 | |
| dc.identifier.uri | https://doi.org/10.1002/ardp.201500212 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley-VCH Verlag GmbH | en_US |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | 2-Pyrazoline | en_US |
| dc.subject | Hydrazone | en_US |
| dc.subject | MAO inhibitors | en_US |
| dc.subject | Molecular docking | en_US |
| dc.title | Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Yelekçi, Kemal | en_US |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü | en_US |
| gdc.description.endpage | 756 | |
| gdc.description.issue | 10 | |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 743 | en_US |
| gdc.description.volume | 348 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W1638969521 | |
| gdc.identifier.pmid | 26293971 | en_US |
| gdc.identifier.wos | WOS:000362565600006 | en_US |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 9.0 | |
| gdc.oaire.influence | 3.550158E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | 2-Pyrazoline | |
| gdc.oaire.keywords | Monoamine Oxidase Inhibitors | |
| gdc.oaire.keywords | Protein Conformation | |
| gdc.oaire.keywords | Moclobemide | |
| gdc.oaire.keywords | Hydrazones | |
| gdc.oaire.keywords | MAO inhibitors | |
| gdc.oaire.keywords | Hydrazone | |
| gdc.oaire.keywords | Molecular Docking Simulation | |
| gdc.oaire.keywords | Kinetics | |
| gdc.oaire.keywords | Structure-Activity Relationship | |
| gdc.oaire.keywords | Drug Design | |
| gdc.oaire.keywords | Molecular docking | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Pyrazoles | |
| gdc.oaire.keywords | Monoamine Oxidase | |
| gdc.oaire.popularity | 7.823281E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 01 natural sciences | |
| gdc.oaire.sciencefields | 0104 chemical sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 1.08430063 | |
| gdc.openalex.normalizedpercentile | 0.78 | |
| gdc.opencitations.count | 23 | |
| gdc.plumx.crossrefcites | 20 | |
| gdc.plumx.mendeley | 27 | |
| gdc.plumx.pubmedcites | 2 | |
| gdc.plumx.scopuscites | 27 | |
| gdc.relation.journal | Archiv Der Pharmazie | |
| gdc.scopus.citedcount | 27 | |
| gdc.virtual.author | Yelekçi, Kemal | |
| gdc.wos.citedcount | 21 | |
| relation.isAuthorOfPublication | 9407938e-3d31-453b-9199-aaa8280a66c5 | |
| relation.isAuthorOfPublication.latestForDiscovery | 9407938e-3d31-453b-9199-aaa8280a66c5 | |
| relation.isOrgUnitOfPublication | 71ce8622-7449-4a6a-8fad-44d881416546 | |
| relation.isOrgUnitOfPublication | 2457b9b3-3a3f-4c17-8674-7f874f030d96 | |
| relation.isOrgUnitOfPublication | b20623fc-1264-4244-9847-a4729ca7508c | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 71ce8622-7449-4a6a-8fad-44d881416546 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Synthesis and Screening of Human Monoamine Oxidase-AInhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.pdf
- Size:
- 1.23 MB
- Format:
- Adobe Portable Document Format
- Description:
